Brad Dahms | Chief Financial Officer |
Carsten Brunn | President and Chief Executive Officer |
Peter Traber | Chief Medical Officer |
Takashi Kishimoto | Chief Scientific Officer |
John Newman | Canaccord Genuity Corp. |
Kristen Kluska | Cantor Fitzgerald & Co. |
Raju Prasad | William Blair & Company, LLC |
Daniel Clark | Mizuho Securities USA LLC |
Good morning and welcome to the Selecta Biosciences Third quarter 2020 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. This call is being webcast live on the Investors & Media section of Selecta's website at www.selectabio.com and it is being recorded.
For opening remarks, I would like to turn it to Brad Dahms, Chief Financial Officer of Selecta. Please go ahead.